Four-month-old boy dies after vaccination in Jammikunta

KARIMNAGAR:  A four-month-old boy died an hour after being administered a vaccine, triggering allegations from parents that the death was caused by a reaction. Doctors, however, denied the claim.

The boy, son of Lingala Anji and Harshitha from Papakkapalli village in Jammikunta mandal, was taken to Vavilala Primary Health Centre on Saturday, where he was given RVV-2 and Penta-2 vaccinations.

After returning home, the child fainted. The parents rushed him to a private hospital in Jammikunta, from where he was shifted to Hanumakonda hospital. He, however, died during treatment.

Family members confronted PHC Medical Officer Dr Varuna, alleging the vaccine caused the death as the boy had no prior health problems.

Dr Varuna clarified that there was no issue with the vaccine, noting that two other children received doses from the same batch on Wednesday without any complications. She said a post-mortem would reveal the exact cause of death if the family had doubts.

Related Posts

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid